We're excited to announce the completion of proof-of-concept demonstrations showing that our technology can be used effectively for encoding digital data in DNA sequences and that the information that was stored could be retrieved accurately afterward.
https://t.co/2A0ug1IhAX
Picture is worth a thousand words. People are free to speculate whether this is interesting, coincidental, irrelevant or else. Are any SEC strings attached to making a press release about preliminary clinical trial data which can move the stock price up? @matthewherper
@SirWrender hi! Professional advice/Question. Can one convert a music video into a VR immersive video using projection mapping/unreal engine and or whatever else using modern VFX tools? Just curious if we're years away from that or not..
@DJHadersPhD This echoes what Elon Musk always says: "production is hard". Hence, investment in production needs to be rewarding, otherwise achieving scale (in anything) will be a very risky proposition for investors/companies
@elonmusk@Erdayastronaut I love that a construction worker gave you a hug @elonmusk! You give it all. And that moment shows just how inspiring you are to others. No bullshit or trips to space distracting you from the relentless pursuit of making life multiplanetary.
"You’re allowed to change. You’re allowed to leave. You’re allowed to let those years be exactly what they were: time spent growing and learning as a human being..."
A reminder from our #ExperimentalError column that you're allowed to quit your #PhD. https://t.co/91dZ6tfHdd
We've been a little quiet on here recently whilst working on something exciting behind the scenes that we can't wait to share with you tomorrow 🚀
In the meantime, @HarryRickerby explains how we are revolutionising drug discovery with #MachineLearning 👉 https://t.co/HMKEtnohyg
After success of its COVID vaccine, #Moderna looks to prove itself and its mRNA platform against seasonal flu by entering into Phase1/2 vaccine trials. #clinicaltrial#seasonalflu - link in bio! @ Galveston, Texas https://t.co/MhRmuIZ6LO
After success of its COVID vaccine, #Moderna looks to prove itself and its mRNA platform against seasonal flu by entering into Phase1/2 vaccine trials. #clinicaltrial#seasonalflu https://t.co/PbKhNtYy8W
@matthewherper Freedom of scientific information is key to not repeating the same costly mistakes. Too bad that there needs to be a service such as this one in the first place.